This week’s newsletter covers Meta’s alleged surveillance of a state-sanctioned cannabis awards show, debates over measuring cannabis’s environmental footprint, and new research on how cannabis and psychedelics may help with eating disorders, PTSD, and anxiety.
Noteworthy Read
Meta Spies on Cannabis Awards Show, Closes Accounts of Winners & Competitors (Cannabis Law Report)
This op-ed from Budist CEO Jocelyn Sheltraw describes how Meta — parent company of Facebook and Instagram — allegedly monitored California’s state-sanctioned cannabis competition, then shut down the social media accounts of several winners and participants. The move raises questions about discriminatory practices against licensed operators.
More Noteworthy Reading
The Blind Men & the Elephant: Measuring the Environmental Impact of Cannabis (Journal of Illicit Economies and Development)
This paper critiques how cannabis’s environmental impacts are measured, arguing that fragmented perspectives obscure a full understanding of the industry’s ecological footprint. The authors call for more comprehensive, standardized methods.
Study: Cannabis and Psychedelics Ease Eating Disorders (The Brighter Side)
A global study finds that cannabis and psychedelic use is associated with reduced symptoms of eating disorders. Researchers highlight the potential therapeutic role of these substances in mental health care.
Read more
View more in Psychedelics
Ibogaine Treatment Linked to Brain Changes & Psychiatric Improvement in Veterans with PTSD (Psypost)
New research shows that ibogaine treatment alters brain rhythms and improves psychiatric outcomes in veterans with traumatic brain injury and PTSD. The findings suggest ibogaine may support recovery from severe trauma.
Read more
View more in Psychedelics
Research Round-Up
Single Dose of LSD Keeps Anxiety at Bay (NPR)
A clinical trial found that one dose of LSD significantly reduced anxiety in people with generalized anxiety disorder, with benefits lasting weeks. The results add to growing evidence for psychedelics in mental health treatment.
Read more
View more in Psychedelics
A heartfelt thank you to all the CBD brands whose generous support fuels Project CBD’s mission to bring you the latest in plant medicine research and reporting — we couldn’t do this work without you.
